Hanne Hella
Trondheim, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Toll-like receptor signaling in multiple myeloma cells promotes the expression of pro-survival genes B-cell lymphoma 2 and MYC and modulates the expression of B-cell maturation antigen.
Journal: Frontiers in immunology
Published: February 29, 2024
Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma.
Journal: Scientific reports
Published: November 20, 2023
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells.
Journal: Scientific reports
Published: November 11, 2022
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells.
Journal: Cell communication and signaling : CCS
Published: June 24, 2022
TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan.
Journal: Oncotarget
Published: July 30, 2021
BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Journal: Journal of cell science
Published: November 23, 2017
Caspase-8 regulates the expression of pro- and anti-inflammatory cytokines in human bone marrow-derived mesenchymal stromal cells.
Journal: Immunity, inflammation and disease
Published: May 26, 2016
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells.
Journal: Blood cancer journal
Published: April 27, 2016
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
Journal: Cell communication and signaling : CCS
Published: January 26, 2015
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
Journal: European journal of haematology
Published: July 17, 2013
Last Updated: 09/26/2026